Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 2/20 | 0.44 |
| ▸ | PLAAT5 | Q96KN8 | 2/20 | 0.44 |
| ▸ | PLAAT2 | Q9NWW9 | 2/20 | 0.44 |
| ▸ | PLAAT4 | Q9UL19 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.43 |
| ▸ | HTR3B | O95264 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1920501 | 1.00 | TAAR1 (0.48) | TAAR1ALDH1A1CTBP2KMT2ASMN1; SMN2 | |
| SCHEMBL19656182 | 0.83 | TAAR1 (0.46) | TAAR1HCAR2MAOAMAOB | |
| SCHEMBL1137527 | 0.83 | CHRM2 (0.47) | TAAR1CTBP2CHRM2CHRM1CHRM3 | |
| SCHEMBL679743 | 0.83 | GPR52 (0.49) | TAAR1ALDH1A1CTBP2MAOB | |
| SCHEMBL1137523 | 0.83 | CHRM2 (0.47) | TAAR1CTBP2CHRM2CHRM1CHRM3 | |
| SCHEMBL12003262 | 0.83 | GPR52 (0.49) | TAAR1ALDH1A1CTBP2MAOB | |
| SCHEMBL197322 | 0.82 | GRIK1 (0.53) | ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL197321 | 0.82 | GRIK1 (0.53) | ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL445494 | 0.82 | GPR52 (0.49) | PLAAT3PLAAT5PLAAT2PLAAT4AOC3 | |
| SCHEMBL1921015 | 0.82 | GPR52 (0.49) | PLAAT3PLAAT5PLAAT2PLAAT4AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2341102-B1 | Thermoplastic resin composition revealing improved impact strength and melt flow property | CHEIL IND INC (KR) | 2015-12-02 | — | — | EP | claimed |
| US-8907013-B2 | Polycarbonate resin composition and molded product using the same | CHEIL INDUSTRIES INC. (KR) | 2014-12-09 | — | — | US | claimed |
| US-8835558-B2 | Polylactic acid/polycarbonate resin composition and molded product made using the same | CHEIL INDUSTRIES INC. (KR) | 2014-09-16 | — | — | US | claimed |
| EP-2199342-B1 | Polylactic acid/polycarbonate resin composition and molded product made using the same | CHEIL IND INC (KR) | 2014-07-30 | — | — | EP | claimed |
| US-8735490-B2 | Thermoplastic resin composition having improved impact strength and melt flow properties | CHEIL INDUSTRIES INC. (KR) | 2014-05-27 | — | — | US | claimed |
| US-20110281995-A1 | Polycarbonate Resin Composition and Molded Product Using the Same | CHEIL INDUSTRIES INC. (KR) | 2011-11-17 | — | — | US | claimed |
| EP-2341102-A1 | Thermoplastic resin composition revealing improved impact strength and melt flow property | Cheil Industries Inc. (KR) | 2011-07-06 | — | — | EP | claimed |
| US-20110160377-A1 | Thermoplastic Resin Composition Having Improved Impact Strength and Melt Flow Properties | CHEIL INDUSTRIES INC. (KR) | 2011-06-30 | — | — | US | claimed |
| US-20100160559-A1 | Polylactic Acid/Polycarbonate Resin Composition and Molded Product Made Using the Same | CHEIL INDUSTRIES INC. (KR) | 2010-06-24 | — | — | US | claimed |
| EP-2199342-A2 | Polylactic acid/polycarbonate resin composition and molded product made using the same | Cheil Industries Inc. (KR) | 2010-06-23 | — | — | EP | claimed |
| EP-1080382-B1 | HIGH REFRACTIVE INDEX OPHTHALMIC DEVICE MATERIALS | ALCON INC (CH) | 2009-07-08 | — | — | EP | claimed |
| US-11859034-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| WO-2023249389-A1 | ENCAPSULATION COMPOSITION FOR ORGANIC LIGHT-EMITTING ELEMENTS, AND ORGANIC LIGHT-EMITTING ELEMENT DISPLAY DEVICE COMPRISING ORGANIC LAYER FORMED THEREFROM | 삼성에스디아이 주식회사 | 2023-12-28 | — | — | WO | disclosed |
| WO-2023203837-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023203845-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| US-20110160377-A1 | Thermoplastic Resin Composition Having Improved Impact Strength and Melt Flow Properties | CHEIL INDUSTRIES INC. (KR) | 2011-06-30 | — | — | US | disclosed |
| US-20100160559-A1 | Polylactic Acid/Polycarbonate Resin Composition and Molded Product Made Using the Same | CHEIL INDUSTRIES INC. (KR) | 2010-06-24 | — | — | US | disclosed |
| EP-2199342-A2 | Polylactic acid/polycarbonate resin composition and molded product made using the same | Cheil Industries Inc. (KR) | 2010-06-23 | — | — | EP | disclosed |
| EP-2184321-A2 | Thermoplastic resin composition and molded product made using the same | Cheil Industries Inc. (KR) | 2010-05-12 | — | — | EP | disclosed |
| US-20100113697-A1 | Thermoplastic Resin Composition and Molded Product Made Using the Same | CHEIL INDUSTRIES INC. | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11859034-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SEM1, ASH2L, CBLC | TAAR1 1794/4885ALDH1A1 2028/4885CTBP2 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.